The Supreme Cannabis company has signed a letter of intent ("LOI") with Malta Enterprises, the economic development agency of Malta.
"The LOI is the first step of Supreme Cannabis' application for a Cannabis Production License in Malta. Such License would allow us to produce and process cannabis for medical use within Malta, one of Europe's principal commercial entry points, and to export cannabis for medical use to certain international markets. If approved, Supreme Cannabis intends to produce products containing EU GMP quality cannabis oil and pursue regulated medical cannabis distribution opportunities in the European Union.", the team with the company explains.
"Malta is not only a strategic hub for Europe, it is also home to robust existing pharmaceutical and nutraceutical manufacturing industries with a deep pool of expertise," says Navdeep Dhaliwal, CEO of The Supreme Cannabis Company. "Using the intellectual property and expertise we've gained in Canada, we intend to deliver our cannabis products to medical patients in multiple international markets."
For more information:
Supreme Cannabis
[email protected]
www.supreme.ca